About one third of cirrhotic patients with esophageal varices eventually bleed from ruptured
varices. The incidence of rebleeding is extremely high during the first 6 weeks after the initial …

Background Oesophageal disorders and chronic liver disease are common worldwide and
significantly impact quality of life. The intricate link between these conditions, including how …

Objectives Proton pump inhibitors (PPIs) are widely prescribed to patients with liver
cirrhosis. We hypothesized that long-standing PPI use is associated with spontaneous …

Abstract Proton Pump Inhibitors (PPI) are very effective in inhibiting acid secretion and are
extensively used in many acid related diseases. They are also often used in patients with …

Gastrointestinal motility is impaired in a substantial proportion of patients with cirrhosis.
Cirrhosis‐related autonomic neuropathy, increased nitric oxide production, and gut …

Bleeding from gastric varices (GVs) is generally considered more severe than that from
esophageal varices (EVs) but occurs less frequently. We review the risk factors for bleeding …

Aim: This was to describe the different types of lesions that can be found in patients with liver
cirrhosis during upper gastrointestinal endoscopy. Patients and Methods: Consecutive …

Abstract Background and Aims Bleeding from esophageal and gastric varices is a fatal event
in patients with liver cirrhosis and portal hypertension. However, the effects of H elicobacter …

Neurogastroenterology and motility disorders are complex gastrointestinal conditions that
are prevalent worldwide, particularly affecting women and younger individuals. These …

BACKGROUND: Portal hypertension in patients with liver cirrhosis causes manifestations
such as esophageal varices, ascites and edema. Some studies have been conducted about …